RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Jun 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-06-04

Reporting Person: Schorno Dean L (EVP &Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-04	Employee Stock Option (Right to Buy)	$3.44	A	167500	Acquired	2028-06-04	Common Stock (167500)	Direct

Footnotes

F1: One fourth (1/4th) of the option vests one year from June 4, 2018 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.